Results 21 to 30 of about 323,328 (291)

Phylogeny of Yellow Fever Virus, Uganda, 2016

Emerging Infectious Diseases, 2018
In April 2016, a yellow fever outbreak was detected in Uganda. Removal of contaminating ribosomal RNA in a clinical sample improved the sensitivity of next-generation sequencing. Molecular analyses determined the Uganda yellow fever outbreak was distinct
Holly R. Hughes, John Kayiwa, Eric C. Mossel, Julius Lutwama, J. Erin Staples, Amy J. Lambert   +5 more
doaj   +1 more source

A mathematically assisted reconstruction of the initial focus of the yellow fever outbreak in Buenos Aires (1871) [PDF]

, 2013
We discuss the historic mortality record corresponding to the initial focus of the yellow fever epidemic outbreak registered in Buenos Aires during the year 1871 as compared to simulations of a stochastic population dynamics model.
Fernández, M. L., Otero, M., Schweigmann, N., Solari, H. G.   +3 more
core   +3 more sources

Yellow Fever in Africa: Estimating the Burden of Disease and Impact of Mass Vaccination from Outbreak and Serological Data [PDF]

, 2014
Background:Yellow fever is a vector-borne disease affecting humans and non-human primates in tropical areas of Africa and South America. While eradication is not feasible due to the wildlife reservoir, large scale vaccination activities in Africa during ...
Burke, D, De La Hoz, F, Ferguson, NM, Garske, T, Grenfell, B, Hansen, PM, Hutubessy, R, Lewis, RF, Perea, W, Ronveaux, O, Staples, JE, Van Kerkhove, MD, Yactayo, S   +12 more
core   +1 more source

The thermal stability of yellow fever vaccines

Memorias do Instituto Oswaldo Cruz, 1990
The assessment of yellow fever vaccine thermostability both in lyophilized form and after reconstitution were analyzed. Two commercial yellow fever vaccines were assayed for their thermal stability. Vaccines were exposed to test temperatures in the range
Ricardo Ishak, Colin R. Howard
doaj   +1 more source

Landscape connectivity for yellow fever: a proxy approach to detect displacement and circulation through environmental corridors and interfaces

The Lancet Planetary Health, 2021
Background: Yellow fever is an arboviral haemorrhagic disease transmitted by mosquitoes in the tropical regions of Africa and South America. WHO estimates that there are 200 000 severe cases and 30 000 deaths worldwide annually. In Brazil, the wild cycle
André Luís Acosta, PhD, Adriano Pinter, PhD, Nuno Faria, PhD, Ester Sabino, PhD, Maria Anice Mureb Sallum, PhD   +4 more
doaj   +1 more source

Travel pattern and profile of clients using online registration system and mobile accessibility for vaccination in a newly established yellow fever vaccination clinic at AIIMS Patna, India

Indian Journal of Community and Family Medicine, 2017
Background: Prevention of Yellow Fever (YF) in travellers to Yellow Fever endemic zone can be done with YF 17D vaccine which is a live attenuated vaccine and can be given only up to one hour after reconstitution.
Dhananjay Kumar, Pragya Kumar, Neeraj Agarwal, Chandra Mani Singh, Sanjay Pandey, Alok Ranjan   +5 more
doaj   +1 more source

Efficacy of Two Common Methods of Application of Residual Insecticide for Controlling the Asian Tiger Mosquito, Aedes albopictus (Skuse), in Urban Areas [PDF]

, 2015
After its first introduction in the 1980's the Asian tiger mosquito, Aedes albopictus (Skuse), has spread throughout Southern Europe. Ae. albopictus is considered an epidemiologically important vector for the transmission of many viral pathogens such as ...
Baseggio, A., Drago, A., Manella, P., Marini, L., Martini, S., Mazzon, L., Romi, R.   +6 more
core   +3 more sources

Anamnestic immune response to dengue and decreased severity of yellow fever

Journal of Global Infectious Diseases, 2009
A protective immunity against yellow fever, from cross-reactive dengue antibodies, has been hypothesized as an explanation for the absence of yellow fever in Southern Asia where dengue immunity is almost universal.
Ricardo O Izurieta, Maurizio Macaluso, Douglas M Watts, Robert B Tesh, Bolivar Guerra, Ligia M Cruz, Sagar Galwankar, Sten H Vermund   +7 more
doaj   +1 more source

Descriptive Characterization of Suspected Yellow Fever Cases in Kano state, Nigeria, 2015-2018

Journal of Interventional Epidemiology and Public Health, 2021
Introduction: Yellow fever remains a serious public health problem globally with an estimated 200, 000 cases annually despite the availability of an effective vaccine for more than 70 years. Nigeria had an outbreak of Yellow fever in 2017 after more than
Usman Yahya Umar, Kabiru Sabitu, Shehu Sani Mohammed, Nura Yahya Karaye, Muhammad Shakir Balogun   +4 more
doaj   +1 more source

Anti‐PD‐1 Nanobody‐Armored MSLN CAR‐T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies

Advanced Science, EarlyView.
A novel therapy using engineered immune cells (NAC‐T cells) showed promise for refractory malignant mesothelioma. Based on the encouraging preclinical data, the first‐in‐human trial is initiated, demonstrating tolerable safety and promising anti‐tumor activity (ORR 63.6%, DCR 100%, including one CR).
Yan Sun, Haochen Yang, Qing Xu, Xingya Li, Jinxing Lou, Jianchun Duan, Jiachen Xu, Zhuqing Liu, Yong Xia, Zhicai Lin, Linlin Li, Dan Sun, Jiaguo Li, Tao Liu, Jun Guo, Wenfeng Xu, Weimin Zhu, Yi Liu, Boyang Sun, Jia Zhong, Lijie Rong, Qijun Qian, Chenqi Xu, Jie Wang   +23 more
wiley   +1 more source